Figure 4.
IgAN patients who had higher than median IL-18 levels (346.80 pg/mL) at baseline had worse renal outcome in follow-up period (Log rank P = 0.03). In this figure, green line represents those patients with higher sIL-18 levels.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.